Olanzapine and Fluoxetine
These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE and FLUOXETINE CAPSULES, for oral use. Initial U.S. Approval: 2003
2f6ceda3-3edc-4427-98a6-23e3c930c44d
HUMAN PRESCRIPTION DRUG LABEL
Jan 29, 2024
Par Pharmaceutical, Inc.
DUNS: 092733690
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
olanzapine and fuoxetine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
olanzapine and fuoxetine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
olanzapine and fuoxetine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
olanzapine and fuoxetine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
olanzapine and fuoxetine
Product Details
FDA regulatory identification and product classification information